Vivos (RDGL) Return on Capital Employed Growth (5y) (2016 - 2025)
Vivos (RDGL) Return on Capital Employed Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -32,612.00 |
| Sep 30, 2025 | -20,638.00 |
| Dec 31, 2024 | -25,237.00 |
| Sep 30, 2024 | -41,322.00 |
| Jun 30, 2024 | -37,780.00 |
| Mar 31, 2024 | -44,731.00 |
| Dec 31, 2023 | -47,151.00 |
| Sep 30, 2023 | -16,687.00 |
| Jun 30, 2023 | -16,300.00 |
| Mar 31, 2023 | -17,994.00 |
| Dec 31, 2022 | -20,039.00 |
| Sep 30, 2022 | -19,723.00 |
| Jun 30, 2022 | -24,209.00 |
| Mar 31, 2022 | -34,651.00 |
| Dec 31, 2021 | -29,737.00 |
| Sep 30, 2021 | -30,810.00 |
| Jun 30, 2021 | -25,314.00 |
| Mar 31, 2021 | -9,329.00 |
| Dec 31, 2020 | 14,409.00 |
| Sep 30, 2020 | 7,839.00 |